AI Buyer Insights:

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Michelin, an e2open customer evaluated Oracle Transportation Management

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Michelin, an e2open customer evaluated Oracle Transportation Management

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Vascular Biogenics Ltd. Data, Technology Stack, and Enterprise Applications
Collaboration
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Microsoft Legacy Microsoft 365 Collaboration Collaboration n/a 2019 2019
IT Decision Makers and Key Stakeholders at Vascular Biogenics Ltd.
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by Vascular Biogenics Ltd. Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Vascular Biogenics Ltd. Technographics

Vascular Biogenics Ltd. is a Life Sciences organization based in Israel, with around 41 employees and annual revenues of $1.0 million.

Vascular Biogenics Ltd. operates a diverse technology stack with applications such as Microsoft Azure Cloud Services and Microsoft 365, covering areas like Application Hosting and Computing Services and Collaboration.

Vascular Biogenics Ltd. has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Microsoft.

Vascular Biogenics Ltd. recently adopted applications including Amazon EC2 in 2022, DigitalOcean Droplets in 2022 and Amazon CloudFront in 2022, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of Vascular Biogenics Ltd.’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates Vascular Biogenics Ltd.’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete Vascular Biogenics Ltd. technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.